Patents by Inventor James Brett Case

James Brett Case has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV-2 inhibitors
    Publication number: 20230250134
    Abstract: Polypeptide inhibitors of SARS-COV-2 are disclosed comprising an amino acid sequence at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identical to the amino acid sequence selected from the group consisting of SEQ ID NOS: 1-17, 19-21, 23-34 and 100-101, and their use for treating and limiting development of SARS-COV-2 infection.
    Type: Application
    Filed: May 25, 2021
    Publication date: August 10, 2023
    Inventors: Longxing CAO, Brian COVENTRY, Inna GORESHNIK, Lauren MILLER, David BAKER, Lisa KOZODOY, John BOWEN, Lauren CARTER, James Brett CASE, Michael DIAMOND, Natasha EDMAN, Andrew HUNT, Michael Christopher JEWETT, Cassandra Jean OGOHARA, Young-jun PARK, Rashmi RAVICHANDRAN, Lance Joseph STEWART, David VEESLER, Bastian VOGELI, Alexandra C. WALLS, Kejia WU, Scott BOYKEN, George UEDA
  • ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES
    Publication number: 20220017604
    Abstract: The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present invention also relates to various pharmaceutical compositions and methods of treating coronavirus using the antibodies or antigen-binding fragments.
    Type: Application
    Filed: April 16, 2021
    Publication date: January 20, 2022
    Applicant: Washington University
    Inventors: Ali Ellebedy, Aaron Schmitz, Jackson Turner, Wafaa Al Soussi, Michael Diamond, Daved Fremont, James Brett Case, Haiyan Zhao, Adrianus Boon, Sean Whelan, Andrew McCluskey, Christopher Negron